Evidence map›Paper›PMID 40845156›Full record

ArticleBioinformatics (Oxford, England)2025

An innovative peptide toxicity prediction model based on multi-scale convolutional neural network and residual connection.

Shengli Zhang, Jingyi Ren, Yunyun Liang

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. INBAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Shengli ZhangSchool of Mathematics and Statistics, Xidian University, Xi'an 710071, P. R. China.ORCID 0000-0001-8786-0940
Jingyi RenSchool of Mathematics and Statistics, Xidian University, Xi'an 710071, P. R. China.
Yunyun LiangSchool of Science, Xi'an Polytechnic University, Xi'an 710048, P. R. China.

Funding

National Natural Science Foundation of China 12101480the Natural Science Basic Research Program of Shaanxi 2024JC-YBMS-004Xidian University Specially Funded Project for Interdisciplinary Exploration TZJH2024028
6 · The paper itself

Abstract

motivationPeptide toxicity is a critical concern in the development of peptide-based therapeutics, as toxic peptides can lead to severe side effects, including organ damage, immune reactions, and cytotoxicity. Predicting peptide toxicity accurately is essential to ensure the safety and efficacy of these drugs.

resultsIn this study, we propose a novel model, ToxMSRC, to predict peptide toxicity using a combination of the continuous bag of words (CBOW) method from word2vec, synthetic minority over-sampling technique (SMOTE), multi-scale convolutional neural networks (CNN), and bidirectional long short-term memory (BiLSTM). This approach addresses the challenge of data imbalance by augmenting positive samples and improves feature extraction through multi-scale convolution. Furthermore, the model incorporates a residual connection that helps prevent overfitting and enhances generalization ability, improving classification performance. The model is evaluated on benchmark and independent test sets, achieving BACC scores of 92.17% on independent test1 and 86.89% on independent test2, outperforming existing state-of-the-art models. Additionally, ToxMSRC provides valuable insights into the relationship between peptide toxicity and amino acid sequences, demonstrating its potential and practical value in peptide-based drug development. AVAILABILITY AND IMPLEMENTATION: The complete datasets, source code, and pre-trained models are made available at https://github.com/Renjingyi123/ToxMSRC and https://doi.org/10.5281/zenodo.15668530.

Indexed as

Computational BiologyNeural Networks, ComputerPeptidesAlgorithmsConvolutional Neural NetworksHumansPeptides

Identifiers

PMID40845156
PMCPMC12512130

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.